Bal Pharma has informed that the meeting of Board of Directors of the Company is scheduled to be held on 11th August 2022 on Thursday to take on record and approve the Unaudited financial results of the Company for the quarter ended 30.06.2022. Further, pursuant to amended provisions of SEBI (Prohibition of Insider Trading Regulations),2015 and as per the provisions of Code of Conduct of the Company, the trading window for dealing in securities of the Company by its designated persons/employees and their ‘immediate relatives was closed from 01.07.2022 up to 14.08.2022 48 hours after declaration of financial results of the Company for the quarter ended 30.06.2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: